Unfortunately, solving this problem is not as straightforward as we all would hope.
Editor's note · Context
Burgess highlights the complexity of addressing drug pricing issues.
Share
More from Michael Burgess
I thank the gentleman for yielding. Mr. Speaker, I do rise today in support of S. 2228, the Building Chips in America Act. Last week, Members of the Texas delegation sent a letter to our leadership requesting that we prioritize this…
I thank you for that admonition. I will try to be careful to keep that in mind during my closing remarks. Mr. Speaker, I yield myself the balance of my time. Mr. Speaker, the gentleman from Massachusetts is correct. He has provided me…
I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, I yield 4 minutes to the gentlewoman from New Mexico (Ms. Leger Fernandez), a distinguished member of the Rules Committee.
I reserve the balance of my time. Mr. McGOVERN. Madam Speaker, may I inquire as to how many speakers the gentleman has remaining?





